Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy

Brazilian Journal of Medical and Biological Research

Volumn 48, Issue 6, 2015, Pages 557-567

  Rangel, M P ^a   de Sa V K ^a   Martins, V ^a   Martins, J ^b   Parra, E R ^a   Mendes, A ^b   Andrade, P C ^a   Reis, R M ^d,e,f   Longatto Filho, A ^a,d,e,f   Oliveira, C Z ^f   Takagaki, T ^a   Carraro, D M ^c   Nader, H B ^b   Capelozzi, V L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d UNIVERSITY OF MINHO   (Portugal)

^e UNIVERSITY OF MINHO   (Portugal)

^f BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

ELISA; Hyaluronic acid; Immunohistochemistry; Lung cancer; Sputum

Indexed keywords

HYALURONIC ACID; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ANGIOGENESIS; ARTICLE; BRONCHOSCOPY; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG CANCER; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; VERY ELDERLY; ADVERSE EFFECTS; BIOPSY; CARCINOMA; CASE CONTROL STUDY; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG; LUNG TUMOR; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; SPUTUM; STROMA CELL;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BIOPSY; CARCINOMA; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; SPUTUM; STATISTICS, NONPARAMETRIC; STROMAL CELLS;

EID: 84931075064     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20144300     Document Type: Article

References (40)

1. Schrump D, Altorki N, Henschke C, Carter D, Turrisi A, Gutierrez M. Non-small cell lung cancer. In: De Vita V, Hellman S, Rosenberg S (Editors), Cancer: principles and practice of oncology. 7th edn. Philadelphia: Lippincott Williams & Wilkins; 2005. p 753-754.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2008. http://seer.cancer.gov/archive/csr/1975_2008/.Accessed December 26, 2011.
3. Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol 2006; 1: 331-348, doi: 10.1146/annurev.pathol.1. 110304.100103.
4. de Sá VK, Carvalho L, Gomes A, Alarcã o A, Silva MR, Couceiro P, et al. Role of the extracellular matrix in variations of invasive pathways in lung cancers. Braz J Med Biol Res 2013; 46: 21-31, doi: 10.1590/1414-431X20122263.
5. de Sa V, Olivieri E, Parra ER, Ab’Saber AM, Takagaki T, Soares FA, et al. Hyaluronidase splice variants are associated with histology and outcome in adenocarcinoma and squamous cell carcinoma of the lung. Hum Pathol 2012; 43: 675-683, doi: 10.1016/j.humpath.2011.06.010.
6. Souza P, Rizzardi F, Noleto G, Atanazio M, Bianchi O, Parra ER, et al. Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer. Hum Pathol 2010; 41: 239-248, doi: 10.1016/j.humpath.2009.07.018.
7. Zetter BR. Adhesion molecules in tumor metastasis. Semin Cancer Biol 1993; 4: 219-229.
8. Freemont T. The significance of adhesion molecules in diagnostic histopathology. Curr Diag Pathol 1995; 2: 101-110, doi: 10.1016/S0968-6053(00)80006-X.
9. Yang C, Cao M, Liu H, He Y, Xu J, Du Y, et al. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 2012; 287: 43094-43107, doi: 10.1074/jbc.M112.349209.
10. Papakonstantinou E, Karakiulakis G, Eickelberg O, Perruchoud AP, Block LH, Roth M. A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology 1998; 8: 821-830, doi: 10.1093/glycob/8.8.821.
11. Toole BP. Glycosaminoglycans and morphogenesis. In: Hay ED (Editor), Cell biology and extracellular matrix. New York: Plenum Press; 1991. p 259-294.
12. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4: 528-539, doi: 10.1038/nrc1391.
13. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999; 274: 25085-25092, doi: 10.1074/jbc.274.35.25085.
14. Dentener MA, Vernooy JH, Hendriks S, Wouters EF. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 2005; 60: 114-119, doi: 10.1136/thx.2003.020842.
15. Deed R, Rooney P, Kumar P, Norton JD, Smith J, Freemont AJ, et al. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer 1997; 71: 251-256, doi: 10.1002/(S ICI) 1097- 0215 (19970410)71:2,251:: A IDIJC21.3.0.CO;2-J.
16. Roboz J, Greaves J, Silides D, Chahinian AP, Holland JF. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. Cancer Res 1985; 45: 1850-1854.
17. Pettersson T, Froseth B, Riska H, Klockars M. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 1988; 94: 1037-1039, doi: 10.1378/chest.94.5.1037.
18. Atagi S, Ogawara M, Kawahara M, Sakatani M, Furuse K, Ueda E, et al. Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma. Jpn J Clin Oncol 1997; 27: 293-297, doi: 10.1093/jjco/27.5.293.
19. Welker L, Muller M, Holz O, Vollmer E, Magnussen H, Jorres RA. Cytological diagnosis of malignant mesothelioma-- improvement by additional analysis of hyaluronic acid in pleural effusions. Virchows Arch 2007; 450: 455-461, doi: 10.1007/s00428-007-0375-x.
20. Creaney J, Dick IM, Segal A, Musk AW, Robinson BW. Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma. Lung Cancer 2013; 82: 491-498, doi: 10.1016/j.lungcan.2013.09.016.
21. Nossier AI, Eissa S, Ismail MF, Hamdy MA, Azzazy HM. Direct detection of hyaluronidase in urine using cationic gold nanoparticles: a potential diagnostic test for bladder cancer. Biosens Bioelectron 2014; 54: 7-14, doi: 10.1016/j.bios.2013.10.024.
22. Kramer MW, Escudero DO, Lokeshwar SD, Golshani R, Ekwenna OO, Acosta K, et al. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis. Cancer 2011; 117: 1197-1209, doi: 10.1002/cncr.25565.
23. Passerotti CC, Srougi M, Bomfim AC, Martins JR, Leite KR, Dos Reis ST, et al. Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma. Urol Oncol 2011; 29: 710-715, doi: 10.1016/j.urolonc.2009. 10.006.
24. Passerotti CC, Bonfim A, Martins JR, Dall’Oglio MF, Sampaio LO, Mendes A, et al. Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder. Eur Urol 2006; 49: 71-75, doi: 10.1016/j.eururo.2005.09.015.
25. Pirinen R, Tammi R, Tammi M, Hirvikoski P, Parkkinen JJ, Johansson R, et al. Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 2001; 95: 12-17, doi: 10.1002/1097-0215(20010120)95:1,12::AID-IJC1002.3.0.CO;2-E.
26. Pirinen RT, Tammi RH, Tammi MI, Paakko PK, Parkkinen JJ, Agren UM, et al. Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung. Int J Cancer 1998; 79: 251-255, doi: 10.1002/(SICI)1097-0215(19980619)79:3,251::AIDIJC7.3.0.CO;2-O.
27. Wang C, Tammi M, Guo H, Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 1996; 148: 1861-1869.
28. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 1998; 58: 342-347.
29. Hirvikoski P, Tammi R, Kumpulainen E, Virtaniemi J, Parkkinen JJ, Tammi M, et al. Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma. Virchows Arch 1999; 434: 37-44, doi: 10.1007/s004280050302.
30. Ayars AG, Altman LC, Potter-Perigo S, Radford K, Wight TN, Nair P. Sputum hyaluronan and versican in severe eosinophilic asthma. Int Arch Allergy Immunol 2013; 161: 65-73, doi: 10.1159/000343031.
31. Van Rensburg A, Neethling GS, Schubert PT, Koegelenberg CF, Wright CA, Bolliger CT, et al. Impact of routine sputum cytology in a population at high risk for bronchial carcinoma. Int J Tuberc Lung Dis 2014; 18: 607-612, doi: 10.5588/ijtld.13.0806.
32. Martins JR, Passerotti CC, Maciel RM, Sampaio LS, Dietrich CP, Nader HB. Practical determination of hyaluronan by a new noncompetitive fluorescence-based assay on serum of normal and cirrhotic patients. Anal Biochem 2003; 319: 65-72, doi: 10.1016/S0003-2697(03)00251-3.
33. Antonelli A, D’Amore PA. Density-dependent expression of hyaluronic acid binding to vascular cells in vitro. Microvasc Res 1991; 41: 239-251, doi: 10.1016/0026-2862(91)90025-7.
34. Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S, et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 1995; 82: 19-26, doi: 10.1016/0092-8674(95)90048-9.
35. Anttila MA, Tammi RH, Tammi MI, Syrjanen KJ, Saarikoski SV, Kosma VM. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 2000; 60: 150-155.
36. Knudson W. Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion. Am J Pathol 1996; 148: 1721-1726.
37. Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res 2011; 1: 482-497.
38. Mantoni TS, Lunardi S, Al-Assar O, Masamune A, Brunner TB. Pancreatic stellate cells radioprotect pancreatic cancer cells through beta1-integrin signaling. Cancer Res 2011; 71: 3453-3458, doi: 10.1158/0008-5472.CAN-10-1633.
39. Lokeshwar VB, Obek C, Soloway MS, Block NL. Tumorassociated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 1997; 57: 773-777.
40. Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd edn.: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: e142S-e165S, doi: 10.1378/chest.12-2353.